Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.60 |
| ▸ | CA9 | Q16790 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8651579 | 1.00 | CA1 (0.60) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL28379200 | 1.00 | CA1 (0.60) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL626027 | 1.00 | CA1 (0.60) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL31745727 | 1.00 | CA1 (0.60) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL8650878 | 1.00 | CA1 (0.60) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL11129170 | 1.00 | CA1 (0.60) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL7753310 | 0.97 | CA1 (0.63) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL3480461 | 0.90 | CA1 (0.55) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL12158586 | 0.90 | CA1 (0.55) | CA1CA9ALDH1A1LMNATP53 | |
| SCHEMBL12158580 | 0.83 | LMNA (0.50) | CA1CA9ALDH1A1LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119920823-A | Electrode, preparation method thereof and lithium ion battery | 重庆太蓝新能源有限公司 | 2025-05-02 | — | — | CN | claimed |
| US-20250380688-A1 | SUSTAINED RELEASE PHEROMONE PREPARATION AND CONTROL METHOD USING THE SAME | SHINETSU CHEMICAL CO (JP) | 2025-12-18 | — | — | US | disclosed |
| CN-119920823-A | Electrode, preparation method thereof and lithium ion battery | 重庆太蓝新能源有限公司 | 2025-05-02 | — | — | CN | disclosed |
| CN-114555553-B | Process for preparing dialkyl carbonates and alkanediols | 国际壳牌研究有限公司 | 2024-04-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250380688-A1 | SUSTAINED RELEASE PHEROMONE PREPARATION AND CONTROL METHOD USING THE SAME | GNRHR, GHRHR, SHBG | CA1 117/4885CA9 198/4885ALDH1A1 2877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.